Clinical Trial Update: Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-001) [Phase 1]

View source ↗

Summary

A Phase 1 study (MK-0472-001) of MK-0472 in participants with advanced or metastatic solid tumors; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• MK-0472

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Metastatic Solid Tumors, Advanced Solid Tumors | Phase 1 | Status: RECRUITING